Cula, Nairan M.
HRN: 19-65-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/09/2023
04/15/2023
IV
625mg
Q6H
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes